Reminder: DUA and VRDC access needs to be extended or renewed annually. Read more.
SAS Name
CRNT_CLNCL_STUS
Current clinical status.
Source: Oncology Care Model Data Registry
| Code | Code value |
|---|---|
| Deceased | Patient is deceased |
| Initial diagnosis | Treatment of the disease has started, and the disease has not been re-evaluated since treatment began |
| Local or regional recurrence/Relapse | Recurrence is the local or regional return of a solid tumor cancer after a clinically disease-free interval. Relapse is the return of a leukemia, lymphoma, or other hematopoietic malignancy that was not previously clinically apparent or symptomatic |
| Metastasis | Evidence of cancer in a site other than the primary tumor site that was not present at initial diagnosis or initial relapse |
| No evidence of disease/Remission | When radiological examinations or complete surgical resection of tumor with negative margins show no evidence of cancer in a patient who is being or has been treated for cancer (including a previous recurrence/relapse); or there is no morphological evidence of leukemia |
| Progressive disease | Cancer continues to grow or spread since initial diagnosis |
| Recurrent or progressive disease | Defined as "Local or Regional Recurrence/Relapse" or "Progressive Disease" as above. This status was only available to report prior to July 1, 2017, and will only appear for patients whose episodes had not yet begun |
| Responding | Cancer is decreasing in extent or severity in response to treatment |
| Stable disease | Cancer is neither decreasing nor increasing in extent or severity |
| Stable, Responding, or No Evidence of Disease | Defined as "Stable Disease," "Responding," or "No Evidence of Disease/Remission" as above. This status was only available to report prior to July 1, 2017, and will only appear for patients whose episodes had not yet begun. |
Participants were required to enter current clinical status at least one time during each 6-month episode, and were expected to update the current clinical status if changes occurred. When there was documentation to support a current clinical status value of “Metastasis” during the episode, practices were instructed to prioritize reporting this value over other current clinical statuses that were documented during the episode, if they only going to report one status during the episode. Current clinical status may not have been reported for every episode.